Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA

SUMMARY: The study results indicate that women with osteoporosis initiated on gastro-resistant risedronate have a lower risk of fracture than those initiated on immediate release risedronate or alendronate. A large proportion of women discontinued all oral bisphosphonate therapies within 1 year of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisman, John A., Cortet, Bernard, Boolell, Mitra, Ionescu-Ittu, Raluca, Vekeman, Francis, Heroux, Julie, Thomasius, Friederike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104910/
https://www.ncbi.nlm.nih.gov/pubmed/36872338
http://dx.doi.org/10.1007/s00198-022-06627-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104910/
https://www.ncbi.nlm.nih.gov/pubmed/36872338
http://dx.doi.org/10.1007/s00198-022-06627-0

Ejemplares similares